![Pius Maliakal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Pius Maliakal formerly worked at PTC Therapeutics, Inc., as Director-Clinical Science and Plus Therapeutics, Inc., as Vice President-Clinical Operations from 2023 to 2024.
Dr. Maliakal received his doctorate degree from the University of Otago and graduate degree from Nagpur University.
Former positions of Pius Maliakal
| Companies | Position | End |
|---|---|---|
| CERENOME, INC. | Chief Tech/Sci/R&D Officer | 30/06/2024 |
| PTC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Pius Maliakal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Nagpur University
 Nagpur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Pius Maliakal
